Zealand Pharma A/S, a biotechnology company, has appointed Steven Johnson as Chief Development Officer.

GC Biopharma has partnered with Körber to implement a large-scale Manufacturing Execution System (MES) project across ...

The U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Novavax Inc.’s Nuvaxovid.

This designation highlights the potential of Cellino’s automated technology for scaling up high-quality iPSCs to industrialize next-generation regenerative therapies. Autologous ...

Aptamer Group plc has announced two new development contracts for its Optimer binders and a licensing heads of terms ...

The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s ...

Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.

Sanofi is the latest major pharmaceutical company to increase its investments in the U.S., partly in response to President ...

BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately ...

GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, a phase III-ready investigational specialty medicine.

Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...